| Oct 30 |
Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC
|
| Oct 24 |
3 US Penny Stocks With Market Caps Over $40M
|
| Oct 4 |
Cardiff Oncology: Paramount Data Imminent In Huge First-Line mCRC Market
|
| Aug 12 |
Cardiff: Second Half Of 2024 mCRC Data Is Major Inflection Point
|
| Aug 10 |
Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript
|
| Aug 8 |
Cardiff Oncology GAAP EPS of -$0.26 misses by $0.01, revenue of $0.16M beats by $0.1M
|
| Aug 8 |
Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update
|
| Aug 7 |
Cardiff Oncology Q2 2024 Earnings Preview
|
| Aug 1 |
Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update
|
| Jul 24 |
Companies Like Cardiff Oncology (NASDAQ:CRDF) Are In A Position To Invest In Growth
|
